Effects of hyperbaric exposure on mechanical and electronic parameters of implantable cardioverter-defibrillators

被引:1
|
作者
Guenneugues, Romain [1 ]
Henckes, Anne [1 ]
Mansourati, Vincent [2 ]
Mansourati, Jacques [2 ]
机构
[1] Univ Hosp Brest, Hyperbar Med Unit, Bvd Tanguy Prigent, F-29609 Brest, France
[2] Univ Hosp Brest, Dept Cardiol, Bvd Tanguy Prigent, F-29609 Brest, France
来源
EUROPACE | 2023年 / 25卷 / 05期
关键词
ICD; Hyperbaric exposure; Hyperbaric oxygen therapy;
D O I
10.1093/europace/euad134
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims Hyperbaric oxygen therapy (HBOT) is the standard adjuvant treatment for life-threatening or disabling pathologies. Currently, mechanical and electronic variations of implantable cardioverter-defibrillators (ICD) in hyperbaric conditions have not been evaluated. As a result, many patients eligible for HBOT but ICD recipients cannot undergo this therapy, even in emergency situations. Methods and results Twenty-two explanted ICD of various brands and models were randomized in two groups: single hyperbaric exposure at an absolute pressure of 4000 hPa and 30 iterative hyperbaric exposures at an absolute pressure of 4000 hPa. Mechanical and electronic parameters of these ICD were blindly assessed before, during, and after hyperbaric exposures. Regardless of the hyperbaric exposure, we could not find any mechanical distortion, inappropriate occurrence of anti-tachycardia therapies, dysfunction of tachyarrhythmia therapeutic programming, or dysfunction of programmed pacing parameters. Conclusion Dry hyperbaric exposure seems harmless on ICD tested ex vivo. This result may lead to a reconsideration of the absolute contraindication of emergency HBOT to ICD recipients. A real-life study in these patients with an indication to HBOT should be performed to assess their tolerance to the treatment.
引用
收藏
页数:4
相关论文
共 50 条
  • [31] Sacubitril/Valsartan and implantable cardioverter-defibrillators: evolving therapeutic strategies. A case report
    Morabito, Claudia
    De Fazio, Marianna Gigliotti
    Scarano, Michele
    Parato, Vito Maurizio
    Dattilo, Giuseppe
    Casale, Matteo
    COR ET VASA, 2020, 62 (05) : 479 - 482
  • [32] Crosscultural adaptation and reliability testing of the Implantable Cardioverter-Defibrillator Concerns questionnaire to optimize the care of Polish patients with implantable cardioverter-defibrillators
    Mlynarska, Agnieszka
    Mlynarski, Rafal
    Uchmanowicz, Izabella
    Marcisz-Dyla, Ewa
    Marcisz, Czeslaw
    Golba, Krzysztof
    KARDIOLOGIA POLSKA, 2020, 78 (09) : 906 - 912
  • [33] The rote of implantable cardioverter-defibrillators and sudden cardiac death prevention: indications, device selection, and outcome
    Goldenberg, Ilan
    Huang, David T.
    Nielsen, Jens Cosedis
    EUROPEAN HEART JOURNAL, 2020, 41 (21) : 2003 - +
  • [34] Remote Monitoring of Implantable Cardioverter-Defibrillators A Systematic Review and Meta-Analysis of Clinical Outcomes
    Parthiban, Nirmalatiban
    Esterman, Adrian
    Mahajan, Rajiv
    Twomey, Darragh J.
    Pathak, Rajeev K.
    Lau, Dennis H.
    Roberts-Thomson, Kurt C.
    Young, Glenn D.
    Sanders, Prashanthan
    Ganesan, Anand N.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 65 (24) : 2591 - 2600
  • [35] Putting the "Informed" in the informed consent process for implantable cardioverter-defibrillators: Addressing the needs of the elderly patient
    Eiser, Arnold R.
    Kirkpatrick, James N.
    Patton, Kristen K.
    McLain, Emily
    Dougherty, Cynthia M.
    Beattie, James M.
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2018, 41 (03): : 312 - 320
  • [36] Usefulness of Radiofrequency Ablation of Supraventricular Tachycardia to Decrease Inappropriate Shocks from Implantable Cardioverter-Defibrillators
    Mainigi, Sumeet K.
    Almuti, Khalid
    Figueredo, Vincent M.
    Guttenplan, Nils A.
    Aouthmany, Asma
    Smukler, Jessica
    Sheeron, Bernadette
    Meldrum, Bryan
    Saenz, Agustina D.
    Tran, Gia
    Greenspan, Allan M.
    AMERICAN JOURNAL OF CARDIOLOGY, 2012, 109 (02) : 231 - 237
  • [37] Long-term follow-up of implantable cardioverter-defibrillators in Short QT syndrome
    El-Battrawy, Ibrahim
    Besler, Johanna
    Ansari, Uzair
    Liebe, Volker
    Schimpf, Rainer
    Tueluemen, Erol
    Rudic, Boris
    Lang, Siegfried
    Odening, Katja
    Cyganek, Lukas
    Wolpert, Christian
    Zhou, Xiaobo
    Borggrefe, Martin
    Akin, Ibrahim
    CLINICAL RESEARCH IN CARDIOLOGY, 2019, 108 (10) : 1140 - 1146
  • [38] Implantable cardioverter-defibrillators in adults with congenital heart disease: a systematic review and meta-analysis
    Vehmeijer, Jim T.
    Brouwer, Tom F.
    Limpens, Jacqueline
    Knops, Reinoud E.
    Bouma, Berto J.
    Mulder, Barbara J. M.
    de Groot, Joris R.
    EUROPEAN HEART JOURNAL, 2016, 37 (18) : 1439 - 1448
  • [39] Implantable cardioverter-defibrillators in sudden cardiac death prevention: guidelines and clinical practice (literature review)
    Talibullin, I., V
    Lebedeva, N. B.
    BYULLETEN SIBIRSKOY MEDITSINY, 2022, 21 (01): : 183 - 196
  • [40] Decision-Making of Patients With Implantable Cardioverter-Defibrillators at End of Life: Family Members' Experiences
    Lee, Mei Ching
    Sulmasy, Daniel P.
    Gallo, Joseph
    Kub, Joan
    Hughes, Mark T.
    Russell, Stuart
    Kellogg, Anela
    Owens, Sharon G.
    Terry, Peter
    Nolan, Marie T.
    AMERICAN JOURNAL OF HOSPICE & PALLIATIVE MEDICINE, 2017, 34 (06) : 518 - 523